Single-arm, open-label, dose escalation phase I study to evaluate the safety and feasibility of transcranial direct current stimulation with electroencephalography biomarkers in paediatric disorders of consciousness: a study protocol

BMJ Open. 2019 Aug 10;9(8):e029967. doi: 10.1136/bmjopen-2019-029967.

Abstract

Introduction: Children with disorders of consciousness (DOC) represent the highest end of the acquired brain injury (ABI) severity spectrum for survivors and experience a multitude of functional impairments. Current clinical management in DOC uses behavioural evaluation measures and interventions that fail to (1) describe the physiological consequences of ABI and (2) elicit functional gains. In paediatric DOC, there is a critical need to develop evidence-based interventions to promote recovery of basic responses to improve rehabilitation and aid decision-making for medical teams and caregivers. The purpose of this investigation is to examine the safety, tolerability and feasibility of transcranial direct current stimulation (tDCS) in children with DOC.

Methods and analysis: This study is an open-label dose escalation trial evaluating the safety, tolerability and feasibility of tDCS in 10 children (5-17 years) receiving inpatient rehabilitation for DOC. This study will follow a modified rule-based design, allowing for intrapatient escalation, where a cohort of patients will be assigned to an initial tDCS current of 0.5 or 1 mA based on participant's head circumference and according to the safety data available in other paediatric populations. The subsequent assignment of increased current (1 or 2 mA) according to the prespecified rules will be based on the clinical observation of adverse events in the patients. The study will include up to three, 20 min sessions of anodal tDCS (sham, 0.5 or 1 mA, 1 or 2 mA) applied over the dorsolateral prefrontal cortex. The primary outcomes are adverse events, pain associated with tDCS and intolerable disruption of inpatient care. Secondary outcomes are changes in electroencephalography (EEG) phase-locking and event-related potential components and the Coma Recovery Scale-Revised total score from prestimulation to poststimulation.

Ethics and dissemination: The Johns Hopkins IRB (#IRB00174966) approved this study. Trial results will be disseminated through journals and conferences.

Registration number: NCT03618849.

Keywords: brain injuries; child; electroencephalography; tDCS; transcranial direct current stimulation.

Publication types

  • Clinical Trial Protocol
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Biomarkers
  • Brain Injuries, Traumatic / diagnosis
  • Brain Injuries, Traumatic / physiopathology
  • Brain Injuries, Traumatic / therapy*
  • Child
  • Child, Preschool
  • Clinical Trials, Phase I as Topic
  • Consciousness Disorders / diagnosis
  • Consciousness Disorders / physiopathology
  • Consciousness Disorders / therapy*
  • Electroencephalography
  • Feasibility Studies
  • Humans
  • Proof of Concept Study
  • Transcranial Direct Current Stimulation / adverse effects*
  • Transcranial Direct Current Stimulation / methods*
  • Treatment Outcome

Substances

  • Biomarkers

Associated data

  • ClinicalTrials.gov/NCT03618849